Discovering a medical breakthrough and turning it into a viable commercial product takes brains. Perseverance. Business savvy. And capital. Lots of capital.
But raising enough capital to launch and grow a biotech startup can be a lengthy and somewhat arduous process for any scientist or innovator who spends more time in labs than boardrooms.
Moreover, biotech startups are, by their very nature, built on emerging technologies, which often come with inherent risks, the kind many investors shy away from. Read the full article here.